Skip to main content

Main navigation

  • Expertise
  • Publications & Insights
  • People
  • Careers

Secondary navigation

  • Value added services
  • CSR
  • About us

SearchSearch results for: “”

197 results

Stibbe represents Simed in dispute with Slotervaart hospital

Stibbe represented Simed International in a dispute with the privately-owned Slotervaart hospital in Amsterdam. The Slotervaart hospital claimed that Simed International had sent incorrect invoices to the Slotervaart hospital, which would therefore have b

Stibbe represents Supervisory Board members of FC Twente

Stibbe represented members of the Supervisory Board of the Dutch professional football club FC Twente when the club faced financial difficulties in 2016.

Stibbe advises client in the pharmaceutical sector

Stibbe assisted a client in the pharmaceutical sector with conducting an in-depth legal assessment regarding the scope and modalities of the safety features to be added to (the packaging of) medicinal products.

Stibbe advises Zeeland Seaports on the bankruptcy of Thermphos

Stibbe advises N.V. Zeeland Seaports ("ZSP") on the bankruptcy of Thermphos International B.V. ("Thermphos"), one of the world's largest producers of phosphorus before it was declared bankrupt in November 2012.

Stibbe advises Merin (formerly Uni-Invest)

Advising Merin (formerly Uni-Invest) on the restructuring of its of its approximately EUR 790 million outstanding CMBS and Mezzanine loans and the sale of the company to Patron Capital and TPG Capital.

Stibbe advises Forbion Capital Partners

Advising Forbion Capital Partners on the delisting of Amsterdam Molecular Therapeutics (AMT) Holding.

Stibbe advises leading plasma protein biotherapeutics company

Stibbe advised a plasma protein biotherapeutics company on Belgium's implementation of a new Act on public procurement law that obliges Belgian hospitals to conduct a public procurement process for public contracts for the supply of medicinal products.

Stibbe advises the Gemeentelijke Holding

Stibbe advised the directors of the Gemeentelijke Holding, one of the main historical shareholders of Dexia NV, throughout the entire crisis period.

Stibbe advises on the contemplated IPO of Agendia

Stibbe advises biotech company

Stibbe advised a leading biotechnology company on the legal aspects of clinical trials development for biotech medicinal products.

Stibbe advises major pharmaceutical company

Stibbe assisted a global innovative pharmaceutical company in a complex co-marketing and co-promotion agreement and advised it on the impact of an innovative product’s registration at the European Medicines Agency.

Stibbe advises on the IPO of Tornier

Stibbe advises Cellerix

Stibbe assisted Cellerix with its merger with Euronext-Brussels-listed Tigenix.

Stibbe represents Heineken

Stibbe represents Heineken as a major creditor in the bankruptcy of the catering company Plassania.

Press release: ATB declared bankrupt, Daisy Nijkamp and Job van Hooff appointed bankruptcy trustees

On 22 April 2022, Amsterdam Trade Bank N.V. ("ATB") filed for bankruptcy and was declared bankrupt by the Amsterdam District Court. The court appointed D.D. Nijkamp and J.E.P.A. van Hooff as bankruptcy trustees.

Restructuring & Insolvency in the Netherlands - 2025

Daisy Nijkamp and Dario Baltussen contributed to the 19th edition of ICLG – Restructuring & Insolvency. In this publication, they provide a practical explanation of Dutch insolvency law and restructuring options for companies in financial difficulties.

The latest Legal Updates straight to your mailbox

We publish high-quality legal knowledge and insights on our website on a daily basis. If you would like to be promptly informed about the latest developments within your areas of interest, we invite you to sign up for our Legal Updates.

De laatste Legal Updates direct in uw mailbox

Dagelijks publiceren wij op onze website hoogwaardige juridische kennis en vooruitzichten. Wilt u snel op de hoogte zijn van de meest actuele ontwikkelingen binnen uw interessegebieden? Meld u dan aan voor onze Legal Updates.

Pagination

  • Previous page
  • Page 8
  • Page 9
  • Current page 10
  • Page 11
  • Next page
Reset filters
Date
Content type
  • Article (65)
  • Event (7)
  • Inside Stibbe (6)
  • Matter (69)
  • Podcast (4)
  • People (46)
Expertise
  • (-) Healthcare and Life Sciences (85)
  • (-) Restructuring and Insolvency (116)
  • Audit Firms and Accountancy (76)
  • Banking and Finance (437)
  • Capital Markets (251)
  • Compliance, Sanctions and Risk (162)
  • Corporate and M&A (884)
  • Corporate Investigations (32)
  • Criminal Law and Enforcement (148)
  • Employment, Benefits and Pensions (419)
  • Energy, Industry and Climate (320)
  • Environment and Planning (913)
  • ESG & Sustainability (307)
  • EU and Competition Law (486)
  • Financial Regulation (176)
  • Infrastructure and Mobility (205)
  • Insurance (36)
  • Intellectual Property (120)
  • Investment Funds (147)
  • Litigation and Arbitration (435)
  • Mass Litigation (92)
  • Privacy and Data Protection (206)
  • Private Equity (200)
  • Procurement Law (128)
  • Public Law (1219)
  • Real Estate (487)
  • Sports (27)
  • Tax (454)
  • Tech (197)
  • Technology, Media and Telecommunications (339)
  • Unfair Competition and Consumer Protection (200)
Jurisdiction
  • BE Law (34)
  • EU Law (18)
  • LU Law (9)
  • NL Law (112)
Language
  • Dutch (25)
  • English (170)
  • French (2)

Footer main navigation

  • Expertise
  • Publications & Insights
  • People
  • Careers
© 2025 Stibbe

Footer navigation

  • Contact
  • Disclaimer
  • General Conditions
  • Register of legal practice areas
  • Privacy and Cookie Policy
  • Important Information